EGF and atrial fibrillation: The anti-angiogenic capacity of AF is based on disruption of EGF-induced EGFR activation [19] and PI3K/Akt/mTOR activation, in which PI3K/Akt/mTOR signaling induces HIF-1 expression in MDA-MB-231 cells [20].